Table 2.
Study | Participants | Probiotic | Dosage (CFU/day) and duration | CNS function | Outcome | Secondary outcome |
---|---|---|---|---|---|---|
Takada et al,50 2016 | 140 healthy students | L. casei Shirota YIT 9029 | 1 × 109 8 weeks |
STAI | No difference of STAI score | Change in salivary cortisol level before exam ↓ Decrease in physical symptoms ↓ |
Mohammadi et al,52 2015 | 70 petrochemical workers | probiotic yogurt (L. acidophilus LA5 + B. lactis Bb12) + placebo capsule; Conventional yogurt (S. thermophilus and L. bulgaricus.) + probiotic capsule (L. casei, L. acidophilus, L. rhamnosus, L. bulgaricus, B. breve, B. longum, S. thermophilus) |
probiotic yogurt: 107 in total Probiotic capsule: 3 × 103, 3 × 107, 7 × 109, 5 × 108, 2 × 1010; 109, 3 × 108, respectively (2.88 × 1010 in total)/6 weeks |
GHQ DASS HPA axis activity |
Improvement of GHQ and DASS in probiotics yogurt and probiotics capsule groups; no difference in HPA axis activity | NA |
Steenbergen et al,53 2015 | 40 healthy volunteers | Ecologic Barrier: B. bifidum W23, B. lactis W52, L. acidophilus W37, L. brevis W63, L. casei W56, L. salivarius W24, Lactococcus lactis (W19 and W58). | 5 × 109 4 weeks |
LEIDS-r BDI BAI |
Improvement of total score and item ‘rumination’ of LEIDS-r. No difference of scores of Beck Depression and Beck Anxiety Inventory |
NA |
Dickerson et al,54 2014 | 65 schizophrenia patients | L. rhamnosus GG (ATCC 53103+ B. animalis subsp. lactis Bb12 |
2 × 109 14 weeks |
PANSS | No difference of toll score or positive, negative or general scores. | Severe difficulty in bowel movement ↓ |
Vaghef-Mehrabany et al,55 2014 | 46 patients with rheumatoid arthritis | L. casei 01 | 108 8 weeks |
STAI | No difference of STAI score | Dietary: NA Cytokines: pro inflammatory cytokine TNF-α, IL-6, and IL-12 ↓, anti-inflammatory cytokine IL-10 ↑ |
Dapoigny et al,56 2012 | 50 IBS patients | L. casei subsp. rhamnosus LCR35 | 6 × 108 4 weeks |
HADS | No difference in HADS score | IBS severity score: only clinically relevant decreased in subtype IBS-D ↓ Presence of Lactobacillus in feces: 85% of patients |
Simrén et al,57 2010 | 74 IBS patients | Milk fermented with yoghurt bacteria L. bulgaricus + S. thermophilus and containing L. paracasei F19 + L. acidophilus La5 + B. lactis Bb12 | 2 × 1010 8 weeks |
HADS | No difference of HADS score | Diet: same among groups |
Whorwell et al,58 2006 | 362 female IBS patients | B. infantis 35624 | 106, 108, 1010 4 weeks |
HADS | No difference in any of the dosages | IBS symptom: ↓ in 108 group |
Reale et al,59 2012 | 72 male smokers | L. casei Shirota | 4 × 1010 3 weeks |
STAI | No difference in STAI score | Natural killer cell activity ↑ CD16+ cell ↑ BMI: NA Bowel function ↑ |
Parracho et al,60 2010 | 15 children (4–16Y) with ASD | L. plantarum WCFS1 | 4.5 × 1010 3 weeks |
DBC | No significant difference in DBC score | Bowel function: only different in stool consistency Fecal microbiota: Lactobacillus Lab 158 ↑, Clostridium Erec482 ↓ |
Messaoudi et al,39 2011 | 55 healthy volunteers | L. helveticus R0052 + B. longum R0175 | 3 × 109 4 weeks |
HSCL-90 HADS PSS CCL |
Improvement of anxiety, depression and problem solving, and reduced UFC level in probiotics group | Median urinary free cortisol ↓ |
Messaoudi et al,61 2011 | 25 healthy volunteers (with lower UFC levels than median value at baseline | L. helveticus R0052 + B. longum R0175 | 3 × 109 4 weeks |
HSCL-90 HADS PSS CCL |
Improvement of anxiety and depression in probiotics group | NA |
Rao et al,51 2009 | 35 CFS patients | L. casei Shirota | 2.4 × 1010 8 weeks |
BDI BAI |
Decreased anxiety symptoms in probiotic group | Fecal microbiota: aerobes ↑, anaerobes ↑ Bifidobacteria ↑, Lactobacillus ↑ |
Benton et al,62 2007 | 124 healthy volunteers | L. casei Shirota (containing milk) | 6.5 × 109 10/20 days |
Questionnaire-based POMS Episodic memory (Wechsler Memory Scale) Retrieval from long-term memory Verbal fluency Eating-associated behavior NART |
Improved mood in the bottom third of the POMS depressed/elated distribution at baseline in probiotics group after 20 days Improved memory in probiotics group after 20 days |
NA |
Tillisch et al,63 2013 | 36 healthy females | FMPP (B. lactis I-2494 [DN-173 010], containing yogurt starters include S. thermophilus I–1630, L. bulgaricus I–1632 and I–1519) and Lactococcus lactis subsp lactis I–1631 |
B. lactis : 1.25 × 1010 S. thermophilus and L. bulgaricus : 1.2 × 109 4 weeks |
Standard emotional faces-attention task for fMRI | Decreased activity to emotional faces in a large distributed network Changes in midbrain connectivity during resting state |
NA |
STAI, State-Trait Anxiety Inventory; NA, not applicable; GHQ, General Health Questionnaire; DASS, Depression Anxiety and Stress Scale; HPA, hypothalamic-pituitary-adrenal; BMI, body mass index; LEIDS-r, Leiden Index of Depression Sensitivity-Revised; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; PANSS, Positive and Negative Symptom Scale; IBS, irritable bowel syndrome; HADS, Hospital Anxiety and Depression Scale; ASD, autism spectrum disorder; IBS-D, diarrhea-predominant IBS; DBC, Development Behavior Checklist; HSCL-90, Hopkins Symptom Checklist; PSS, Perceived Stress Scale; CCL, Coping Checklist; UFC, urinary free cortisol; CFS, chronic fatigue syndrome; POMS, questionnaire-based Profile of Mood State; NART, National Adult Reading Rest; FMPP, fermented milk product with probiotic; fMRI, functional magnetic resonance imaging; B. animalis, Bifidobacterium animalis; B. breve, Bifidobacterium breve; B. bifidum, Bifidobacterium bifidum; B. infantis, Bifidobacterium infantis; B. lactis, Bifidobacterium lactis; B. longum, Bifidobacterium longum; L. acidophilus, Lactobacillus acidophilus; L. brevis, Lactobacillus brevis; L. bulgaricus, Lactobacillus bulgaricus; L. casei, Lactobacillus casei; L. helveticus, Lactobacillus helveticus; L. paracasei, Lactobacillus paracasei; L. plantarum, Lactobacillus plantarum; L. rhamnosus, Lactobacillus rhamnosus; L. salivarius, Lactobacillus salivarius; S. thermophiles, Streptococcus thermophiles.